Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Stromal Tumors (GIST)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01643278
What this trial is testing

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Gastrointestinal Stromal TumorStage III Soft Tissue SarcomaStage IV Soft Tissue Sarcoma
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT00098579
What this trial is testing

Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Stromal TumorRecurrent Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Ended earlyNCT00956072
What this trial is testing

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 12
Large-scale testing (Phase 3)Study completedNCT01694277
What this trial is testing

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 258
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Not applicableLooking for participantsNCT07522762
What this trial is testing

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The Netherlands Cancer Institute 330
Large-scale testing (Phase 3)Looking for participantsNCT07218926
What this trial is testing

IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 450
Testing effectiveness (Phase 2)Study completedNCT00041249
What this trial is testing

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableApproved For MarketingNCT04148092
What this trial is testing

Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, LLC
Testing effectiveness (Phase 2)Study completedNCT01294202
What this trial is testing

Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Astex Pharmaceuticals, Inc. 26
Not applicableStudy completedNCT01865565
What this trial is testing

Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy

Who this might be right for
Gastrointestinal Stromal Tumor
Chang Gung Memorial Hospital 51
Not applicableAvailableNCT06948955
What this trial is testing

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Not applicableTemporarily pausedNCT02924714
What this trial is testing

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Oslo University Hospital 31
Testing effectiveness (Phase 2)UnknownNCT01541709
What this trial is testing

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Next Page